公司資料
Stryker 股價、新聞與催化劑
- 股票代碼:
- SYK
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
331.68 USD (-2.22%)
收盤價
最後更新: 2026年8月17日
112B USD
市值
股價為何變動
As of Aug 17, 2026, SYK closed down 2.22% at $331.68. No new same-company headline was identified in the current news window.
公司概覽
Global MedTech Leader
Stryker is a global medical technology company offering products and services across MedSurg, Neurotechnology, and Orthopaedics. Its scale, global customer base, and product breadth make it one of the largest diversified medtech companies, with products that support surgical procedures, hospital workflows, orthopedic reconstruction, and neurotechnology care.
MedSurg and Neurotechnology Engine
MedSurg and Neurotechnology is Stryker's largest segment, generating $3.6 billion in second-quarter 2026 net sales. Growth was driven mainly by unit volume, showing continued demand across the company's procedural and hospital-facing technology portfolio.
Orthopaedics Franchise
Orthopaedics remains a major growth pillar, with $3.0 billion in second-quarter sales and strong organic growth. Stryker also reorganized elements of its orthopaedic instruments, neuro cranial, spine enabling technologies, and related portfolios to better align with internal reporting and business management.
Operational Resilience
The quarter also reflected recovery from a cyber incident reported earlier in 2026. Despite that disruption, Stryker delivered strong sales, EPS, and operating cash flow growth. This supports the company's positioning as a resilient medtech operator with a steady cadence of innovation and disciplined execution.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。